2024 annual financial data
Telomir Pharmaceuticals 2024 Operating margin
Telomir Pharmaceuticals 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -12,242,174 USD and net income was -16,532,716 USD.
Operating cash flow was -5,070,428 USD.
Get free Telomir Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -12,242,174 USD
- Net income
- -16,532,716 USD
- Operating cash flow
- -5,070,428 USD